FBT First Trust NYSE Arca Biotechnology Index Fund

46

NYSE ARCA | ETF

Price
$148.2
Increased by +0.79%
Dollar Volume (20D)
3.34 M
ADR%
1.49
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Top 20 Holdings

Asset Name Sector Industry Weight
RARE Ultragenyx Healthcare Biotechnology 4%
BGNE BeiGene Ltd Healthcare Biotechnology 3.71%
ITCI Intracellular Th Healthcare Drug Manufacturers - Specialty & Generic 3.68%
QGEN Qiagen NV Healthcare Diagnostics & Research 3.65%
BIIB Biogen Inc Healthcare Drug Manufacturers - General 3.64%
MRNA Moderna Inc Healthcare Biotechnology 3.56%
IQV IQVIA Holdings Inc Healthcare Diagnostics & Research 3.55%
EXEL Exelixis Inc Healthcare Biotechnology 3.49%
AMGN Amgen Inc Healthcare Drug Manufacturers - General 3.46%
NBIX Neurocrine Biosciences Inc Healthcare Drug Manufacturers - Specialty & Generic 3.46%
UTHR United Therapeutics Corporation Healthcare Biotechnology 3.43%
ALKS Alkermes Plc Healthcare Drug Manufacturers - Specialty & Generic 3.41%
CRL Charles River Laboratories Healthcare Diagnostics & Research 3.41%
BNTX BioNTech SE Healthcare Biotechnology 3.41%
IONS Ionis Pharmaceuticals Inc Healthcare Biotechnology 3.37%
HALO Halozyme Therapeutics Inc Healthcare Biotechnology 3.36%
CPRX Catalyst Pharmaceuticals Inc Healthcare Biotechnology 3.35%
VRTX Vertex Pharmaceuticals Inc Healthcare Biotechnology 3.35%
TECH Bio-Techne Corp Healthcare Biotechnology 3.35%
ACAD ACADIA Pharmaceuticals Inc Healthcare Biotechnology 3.34%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.